Crewe Advisors LLC Johnson & Johnson Transaction History

Crewe Advisors LLC

$859 Million
Q3 2024

A detailed history of Crewe Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Crewe Advisors LLC holds 3,927 shares of JNJ stock, worth $572,752. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,927

Previous 4,069 3.49%

Holding current value

$572,752

Previous $594,000 7.07%

% of portfolio

0.07%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $20,658 - $23,767	-142 Reduced 3.49%	3,927 $636,000
Q2 2024 Jul 29, 2024	BUY	$144.38 - $157.78 $23,533 - $25,718	163 Added 4.17%	4,069 $594,000
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $606,289 - $635,662	3,906 New	3,906 $617,000
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $81,188 - $87,373	-526 Reduced 19.84%	2,125 $351,000
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $19,636 - $23,433	130 Added 5.16%	2,651 $410,000
Q4 2022 Feb 07, 2023	SELL	$160.2 - $179.79 $40,050 - $44,947	-250 Reduced 9.02%	2,521 $445,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $30,814 - $34,288	191 Added 7.4%	2,771 $453,000
Q2 2022 Aug 02, 2022	BUY	$168.19 - $186.01 $199,136 - $220,235	1,184 Added 84.81%	2,580 $458,000
Q1 2022 Apr 27, 2022	BUY	$158.14 - $179.59 $99,628 - $113,141	630 Added 82.25%	1,396 $248,000
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $55,667 - $61,764	357 Added 87.29%	766 $131,000
Q1 2021 Apr 21, 2021	BUY	$153.07 - $170.48 $29,848 - $33,243	195 Added 91.12%	409 $67,000
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $16,316 - $18,728	-119 Reduced 35.74%	214 $34,000
Q3 2020 Oct 13, 2020	BUY	$140.38 - $153.83 $42,114 - $46,149	300 Added 909.09%	333 $50,000
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $3,889 - $5,389	-35 Reduced 51.47%	33 $4,000
Q4 2019 Feb 05, 2020	BUY	$127.5 - $146.44 $4,462 - $5,125	35 Added 106.06%	68 $10,000
Q3 2019 Nov 06, 2019	SELL	$126.95 - $142.14 $24,120 - $27,006	-190 Reduced 85.2%	33 $4,000
Q2 2019 Aug 09, 2019	BUY	$131.15 - $144.24 $25,705 - $28,271	196 Added 725.93%	223 $31,000
Q1 2019 May 10, 2019	SELL	$125.72 - $139.79 $40,607 - $45,152	-323 Reduced 92.29%	27 $4,000
Q4 2018 Feb 05, 2019	BUY	$122.84 - $147.84 $18,426 - $22,176	150 Added 75.0%	350 $45,000
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $35,744 - $42,006	-294 Reduced 59.51%	200 $28,000
Q2 2018 Aug 07, 2018	SELL	$119.4 - $131.76 $9,552 - $10,540	-80 Reduced 13.94%	494 $60,000
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $9,257 - $10,962	74 Added 14.8%	574 $74,000
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $65,610 - $71,810	500	500 $70,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.

Account

Crewe Advisors LLC Johnson & Johnson Transaction History